News
September 25, 2007 - The Medicines Company announced that the FDA has accepted its supplemental new drug application (sNDA) for a modified dosing regimen of Angiomax (bivalirudin) for the treatment of acute coronary syndromes (ACS), specifically in patients with unstable angina or non-segment elevation myocardial infarction (NSTEMI), which could replace heparin in patients undergoing angioplasty.
September 24, 2007
News
September 25, 2007 - Cordis Corp. today announced the introduction in the U.S. market of the FIRE STAR Rx PTCA ...
September 24, 2007
Technology
The FIRE STAR Rx PTCA Dilatation Catheter and the DURA STAR Rx PTCA Dilatation Catheter are indicated for expansion in the narrowed area of a coronary artery or bypass graft. The FIRE STAR Balloon features the lowest pre-dilatation profile in the market.
September 24, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
September 25, 2007 - The risk of developing venous thromboembolism while flying on an airplane, a condition known as “economy class syndrome,” is only about one in 5,000 for long flights, although the odds of in-flight clot are higher for some groups, according to a new study out of The Netherlands.
September 24, 2007News
September 24, 2007 - Stentys announced that its drug-eluting bifurcated stent for treatment of blocked coronary artery ...
September 23, 2007News
September 21, 2007-The CYPHER Sirolimus-eluting Coronary Stent reduced by more than half the rate of major adverse ...
September 20, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
September 21, 2007 - Catheter angiography may be unnecessary in cases where the CT angiogram (CTA) is indeterminate for ...
September 20, 2007News
September 20, 2007 - Cook Medical and Cardica Inc. announced that they have expanded their original agreement regarding ...
September 19, 2007News
September 20, 2007 - Medicure Inc. today announced the completion of enrollment of 3,000 patients in its MEND-CABG II trial, as the company plans to develop the first cardioprotective therapy approved to reduce mortality and morbidity in the CABG patient population.
September 19, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
September 19, 2007 - Risk stratification using single-photon emission computed tomography (SPECT) led to shorter stays ...
September 18, 2007News
September 19, 2007 - Polymer Technology Systems Inc. (PTS) announced the availability of a new PTS Panels Test Strip to test important risk factors for cardiovascular disease and diabetes.
September 18, 2007News
September 19, 2007 - With better quality sound, reproducibility potential for computer analysis, file-sharing and ...
September 18, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
September 19, 2007 - MedicalCV Inc. announced that the first closed-chest, beating heart cardiac ablation using the ...
September 18, 2007News
September 18, 2007- With PET-guided lead placement, cardiac resynchronization therapy (CRT) can achieve significant clinical improvement in patients with severe ischemic heart failure, even in the presence of extensive scarring, reported investigators at the American Society of Nuclear Cardiology meeting, held in San Diego, CA, from September 6 – 9.
September 18, 2007News
September 19, 2007 - For patients with equivocal or discordant findings on myocardial perfusion imaging, CT angiography ...
September 18, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now